DUALITY ADVISERS, LP - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUALITY ADVISERS, LP ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$566,417
-68.4%
24,659
-54.8%
0.06%
-67.0%
Q4 2021$1,792,000
+39.1%
54,530
+133.2%
0.19%
+70.2%
Q2 2021$1,288,000
+7.3%
23,380
-31.8%
0.11%
+48.1%
Q3 2020$1,200,00034,2900.08%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 965,369$56,378,00014.98%
Casdin Capital, LLC 237,500$13,870,0008.18%
BB BIOTECH AG 2,839,528$165,828,0005.42%
Opaleye Management Inc. 130,000$7,592,0003.78%
Redmile Group, LLC 902,578$52,711,0003.42%
Clarius Group, LLC 109,230$6,379,0002.63%
Opus Point Partners Management, LLC 57,410$3,353,0002.49%
Ghost Tree Capital, LLC 125,000$7,300,0001.36%
CAPITAL INTERNATIONAL LTD /CA/ 346,937$20,261,0001.32%
Eventide Asset Management 300,800$17,567,0001.16%
View complete list of AGIOS PHARMACEUTICALS INC shareholders